First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Eating more ultra-processed food raises your risk of lung cancer August 4, 2025 Firmicutes bacteria can help maintain bone mass, study suggests May 27, 2025 Antidepressant use associated with higher risk of sudden cardiac death in all age groups March 31, 2025
Antidepressant use associated with higher risk of sudden cardiac death in all age groups March 31, 2025